Somnomed Ltd - Asset Resilience Ratio
Somnomed Ltd (SOM) has an Asset Resilience Ratio of 24.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Somnomed Ltd's Asset Resilience Ratio has changed over time. Check Somnomed Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Somnomed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Somnomed Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$18.50 Million | 24.67% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$18.50 Million | 24.67% |
Asset Resilience Insights
- Good Liquidity Position: Somnomed Ltd maintains a healthy 24.67% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Somnomed Ltd Industry Peers by Asset Resilience Ratio
Compare Somnomed Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Somnomed Ltd (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Somnomed Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 23.18% | AU$16.18 Million ≈ $11.45 Million |
AU$69.80 Million ≈ $49.39 Million |
+4.04pp |
| 2023-06-30 | 19.13% | AU$11.96 Million ≈ $8.46 Million |
AU$62.49 Million ≈ $44.22 Million |
-7.80pp |
| 2022-06-30 | 26.93% | AU$15.64 Million ≈ $11.07 Million |
AU$58.09 Million ≈ $41.10 Million |
-10.65pp |
| 2021-06-30 | 37.58% | AU$21.11 Million ≈ $14.94 Million |
AU$56.17 Million ≈ $39.74 Million |
-11.33pp |
| 2020-06-30 | 48.91% | AU$30.17 Million ≈ $21.35 Million |
AU$61.69 Million ≈ $43.65 Million |
+26.76pp |
| 2019-06-30 | 22.15% | AU$7.70 Million ≈ $5.45 Million |
AU$34.75 Million ≈ $24.59 Million |
-7.14pp |
| 2018-06-30 | 29.29% | AU$13.38 Million ≈ $9.47 Million |
AU$45.70 Million ≈ $32.33 Million |
-5.19pp |
| 2017-06-30 | 34.48% | AU$14.21 Million ≈ $10.05 Million |
AU$41.21 Million ≈ $29.16 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$40.43 Million ≈ $28.60 Million |
-- |
About Somnomed Ltd
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more